Follow BlueStar in the news as we develop the best strategies for investors in Israel.

January: BlueStar Israel Equity Update

February 14, 2017

Israeli Global Equities, as measured byBIGI®, were up 2.54% in January. BIGI® outpaced US equities in January, in-line with other Developed Market equity benchmarks, despite continued dismal performance by the two Israeli pharmaceuticals giants Teva and Perrigo. Israeli pharmaceuticals stocks rallied in the first few trading days of the year but were subsequently hit with massive selling pressure.That selling pressure, one could argue, was defined by some of the traditional characteristics of capitulation selling. Virtually every other sector of the Israeli market gained more than 4%.

View Full Text

Contact Us

Sending

Contact Info

BlueStar Global Investors LLC
1350 Avenue of the Americas
4th floor
New York, NY 10019

(646) 380-2500

info@bluestarglobalinvestors.com
 
Close menu